Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anoro Ellipta vs Umeclidinium in GOLD Stage II COPD
NCT01491802Phase 3Completed
- Sponsor
- Queen's University
- Start
- Jan 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Anoro Ellipta in chronic obstructive pulmonary disease (COPD), sponsored by Queen's University. Started Jan 2012; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01491802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491802.